 JERUSALEM, Jan. 26, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that it is presenting at the Edison Open House: Global Healthcare 2022 conference. 